Daclizumab: A Review in Relapsing Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0708-2
Abstract: Daclizumab (Zinbryta®; previously known as daclizumab high-yield process) is a therapeutic monoclonal antibody that has recently been approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults. Daclizumab is a humanized IgG1… read more here.
Keywords: daclizumab; multiple sclerosis; review relapsing; daclizumab review ... See more keywords
Dimethyl Fumarate: A Review in Relapsing-Remitting MS
Sign Up to like & getrecommendations! Published in 2019 at "Drugs"
DOI: 10.1007/s40265-019-01229-3
Abstract: Dimethyl fumarate (Tecfidera®) is approved for the treatment of relapsing forms of multiple sclerosis (MS). Based on evidence from the clinical trial and real-world settings, dimethyl fumarate is an effective treatment in this patient population,… read more here.
Keywords: relapsing remitting; fumarate review; fumarate; review relapsing ... See more keywords